Precise delivery of therapeutic agents is critical to overcoming the immunosuppressive Tumor Microenvironment (TME). Strategies include enhancing the efficacy of immune checkpoint inhibitors (ICIs), delivering oncolytic viruses, and co-delivering adjuvants with chemotherapeutics. These approaches facilitate the transformation of "cold" tumors into "hot" ones, fostering localized and sustained immune activation at the tumor site and post-surgical margins.
Targeted Drug Delivery for Immunotherapy
Immunotherapy is rapidly changing disease treatment, but its success hinges on superior delivery systems. Creative Biolabs provides state-of-the-art targeted technology, ensuring your immunomodulators reach the immune system's "command center" safely and precisely, achieving the desired activation or tolerance.
What is Targeted Delivery?
Targeted delivery systems (TDS) leverage sophisticated nanotechnology to ensure therapeutic payloads—from small molecules to fragile nucleic acids and large biologics—are concentrated at the desired biological site, such as the tumor microenvironment (TME) or specific immune cell populations. Unlike conventional treatments that distribute drugs throughout the body, TDS utilizes precise biological mechanisms, including Passive Targeting (harnessing the EPR effect), Active Homing (using specific ligands like antibodies or peptides), and Stimuli-Responsive Release (triggered by TME acidity). Our advanced Biomimetic Carriers further enhance this by using cell membranes to evade immune clearance, maximizing drug persistence and efficacy while minimizing systemic toxicity.
Applications for Immunotherapy
Cancer Immunotherapy
Prophylactic & Therapeutic Vaccines
Cutting-edge engineered lipid nanoparticles (LNPs) and polymer carriers are optimized for the efficient delivery of nucleic acid vaccines (mRNA/DNA) and protein antigens. These technologies improve antigen presentation efficiency to dendritic cells (APCs), driving the robust and long-lasting T-cell and B-cell responses essential for next-generation vaccination strategies.
Inflammation & Autoimmune Diseases
Targeted delivery is pivotal for restoring immune homeostasis. Advanced carriers can precisely deliver immunosuppressants or tolerogens to pathological immune cells or inflamed tissues, selectively damping overactive immune responses without compromising the body's systemic defense mechanisms.
Fig.1 NPs targeting different TME components for re-sensitizing tumor cells to immunotherapy.1
Delivery Challenges of Immunotherapy
Targeted delivery directly confronts the key failures of systemic administration:
Targeting and Cellular Uptake In vivo Nucleic Acid/Protein Stability Overcoming the Immunosuppressive Microenvironment (TME) Immunogenicity and Safety
How to ensure that immunomodulators or antigens precisely reach key players like dendritic cells (DCs), T-cells, or tumor-infiltrating lymphocytes (TILs) without excessive off-target accumulation?
What We Can Offer
Creative Biolabs provides specialized solutions built on decades of experience to overcome delivery barriers:
High-Efficiency Nanoparticle Vaccine Platform
We provide customized LNPs and polymer carriers engineered for supreme stability and internalization. This platform ensures the efficient encapsulation of mRNA/DNA vaccines, which significantly improves antigen presentation and subsequent T-cell activation efficiency in vivo.
Targeted Immune Cell Delivery
Utilizing advanced surface modification technologies (such as targeted receptor ligands) and pioneering Biomimetic Coatings, we achieve precise, non-toxic delivery directly to antigen-presenting cells (APCs) or tumor-infiltrating lymphocytes (TILs), maximizing therapeutic specificity.
Multifunctional Combined Delivery
We develop carriers that can simultaneously encapsulate an immune checkpoint inhibitor and an adjuvant or a chemotherapeutic drug. This approach achieves synergistic effects between immunotherapy and traditional therapies, which is crucial for maximizing response rates in immunologically "cold" tumors.
Biological Function Assessment Support
We offer rigorous assessment services for key immunological indicators, including immune cell uptake studies, T-cell activation assays, and cytokine release profiles in sophisticated in vitro and in vivo models, validating the functional success of your delivery system before clinical translation.
Why Choose Us?
Decades of Expertise
We are powered by years of unparalleled experience dedicated solely to advanced drug delivery science.
Regulated Quality Protocols
Our expertise spans rational design and sophisticated analytical characterization, leading directly to validated, high-quality manufacturing protocols essential for rapid clinical translation.
Pioneering Biomimetic Systems
We move beyond conventional carriers by engineering cutting-edge Biomimetic Systems and advanced co-delivery platforms, offering superior immune evasion and targeting capabilities.
Translational Advantage
We provide the decisive advantage of translation-ready, stable, and highly effective targeted delivery solutions engineered to mitigate toxicity and significantly accelerate your time-to-market.
Workflow
Your next-generation immunotherapy deserves cutting-edge delivery technology. Please contact us to collaborate with our team of immune delivery experts and accelerate your research breakthrough.
Reference
- Wu, Peijie, et al. "Nanoparticle-based drug delivery systems targeting tumor microenvironment for cancer immunotherapy resistance: current advances and applications." Pharmaceutics 14.10 (2022): 1990. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/pharmaceutics14101990.
Our services are For Research Use Only. We do not provide services to individuals.
Online Inquiry
